Citations

Clear

4093 citation(s) found for "Yu, Jonathan".

Retinal Vasculopathy With Cerebral Leukoencephalopathy and Systemic Manifestations: Critical Role of Retina Specialists
Houghton, Odette M. , Dhamija, Radhika , Dhamija, Radhika , Carter, Jonathan

Mayo Clinic

Journal of VitreoRetinal Diseases | December 3, 2022 | Volume: 7 | Issue: 2 | Pages: 171-177

10.1177/24741264221129095 | PMID 37006667 Get It

Purpose: To describe a case of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) to enhance early recognition of this often-missed diagnosis. Methods: A case report is presented. Results: A 50-year-old woman with a history of Raynaud phenomenon, memory difficulties, and a family history of strokes was referred for evaluation of a bilateral, small-vessel, occlusive disease refractory to immunosuppressive therapy. An extensive workup for treatable causes was unrevealing. Fifteen months after presentation, brain imaging showed white-matter lesions and dystrophic calcification, which led to the discovery of a pathogenic variant in TREX1 and the diagnosis of RVCL-S. Conclusions: Retina specialists play a critical role in the timely diagnosis of RVCL-S. Although the findings in this condition can mimic those in other common retinal vascular disorders, there are key characteristics that increase the suspicion for RVCL-S. Early recognition might decrease unnecessary therapies and procedures.
Concerns surrounding application of artificial intelligence in hip and knee arthroplasty
Jain, Samagra, Pang, Michael , Karnuta, Jaret M. , Nawabi, Danyal H. , Polisetty, Teja S. , Vigdorchik, Jonathan M. , Wyles, Cody C. , Ramkumar, Prem N.

Mayo Clinic

The Bone & Joint Journal | December 1, 2022 | Volume: 104-B | Issue: 12 | Pages: 1292-1303

10.1302/0301-620x.104b12.bjj-2022-0922.r1 | PMID 36453039 Get It

Literature surrounding artificial intelligence (AI)-related applications for hip and knee arthroplasty has proliferated. However, meaningful advances that fundamentally transform the practice and delivery of joint arthroplasty are yet to be realized, despite the broad range of applications as we continue to search for meaningful and appropriate use of AI. AI literature in hip and knee arthroplasty between 2018 and 2021 regarding image-based analyses, value-based care, remote patient monitoring, and augmented reality was reviewed. Concerns surrounding meaningful use and appropriate methodological approaches of AI in joint arthroplasty research are summarized. Of the 233 AI-related orthopaedics articles published, 178 (76%) constituted original research, while the rest consisted of editorials or reviews. A total of 52% of original AI-related research concerns hip and knee arthroplasty (n = 92), and a narrative review is described. Three studies were externally validated. Pitfalls surrounding present-day research include conflating vernacular (“AI/machine learning”), repackaging limited registry data, prematurely releasing internally validated prediction models, appraising model architecture instead of inputted data, withholding code, and evaluating studies using antiquated regression-based guidelines. While AI has been applied to a variety of hip and knee arthroplasty applications with limited clinical impact, the future remains promising if the question is meaningful, the methodology is rigorous and transparent, the data are rich, and the model is externally validated. Simple checkpoints for meaningful AI adoption include ensuring applications focus on: administrative support over clinical evaluation and management; necessity of the advanced model; and the novelty of the question being answered. Cite this article: Bone Joint J 2022;104-B(12):1292–1303.
Posterior Lateral Meniscal Root and Oblique Radial Tears: The Biomechanical Evidence Supports Repair of These Tears, Although Long‐Term Clinical Studies Are Necessary
LaPrade, Robert F. , Geeslin, Andrew G. , Cohen, Moisés , Engebretsen, Lars , Faucett, Scott C. , Getgood, Alan , Inderhaug, Eivind , Johnson, Darren L., Kopf, Sebastian , Musahl, Volker , Negrín, Roberto , Riboh, Jonathan C. , Spalding, Tim , Engebretsen, Lars , LaPrade, Robert F , Chahla, Jorge , Krych, Aaron J. , Larson, Christopher Michael , Lind, Martin , Moatshe, Gilbert , Murray, Iain R. , Seil, Romain

Mayo Clinic

Arthroscopy | November 30, 2022 | Volume: 38 | Issue: 12 | Pages: 3095-3101

10.1016/j.arthro.2022.09.015 | PMID 36462774 Get It

Thromboelastography Parameters do not Discriminate for Thrombotic Events in Hospitalized Patients With COVID-19
Kartiko, Susan , Yamane, David , Siddique, Abu Bakkar , Levine, Andrea R. , Jackson, Amanda, Wieruszewski, Patrick M. , Smischney, Nathan J. , Chow, Jonathan H. , Investigators, for the CRUSH COVID, Levine, Andrea R , Wieruszewski, Patrick M , Smischney, Nathan J , Chow, Jonathan H , Koizumi, Naoru , Sarani, Babak , Khanna, Ashish K. , Investigators, for the CRUSH COVID

Mayo Clinic

Journal of Intensive Care Medicine | November 30, 2022 | Volume: 38 | Issue: 5 | Pages: 449-456

10.1177/08850666221142265 | PMID 36448250 Get It

Background Coronavirus disease 2019 (COVID-19) is associated with a prothrombotic state; leading to multiple sequelae. We sought to detect whether thromboelastography (TEG) parameters would be able to detect thromboembolic events in patients hospitalized with COVID-19. Methods We performed a retrospective multicenter case–control study of the Collaborative Research to Understand the Sequelae of Harm in COVID (CRUSH COVID) registry of 8 tertiary care level hospitals in the United States (US). This registry contains adult patients with COVID-19 hospitalized between March 2020 and September 2020. Results A total of 277 hospitalized COVID-19 patients were analyzed to determine whether conventional coagulation TEG parameters were associated with venous thromboembolic (VTE) and thrombotic events during hospitalization. A clotting index (CI) >3 was present in 45.8% of the population, consistent with a hypercoagulable state. Eighty-three percent of the patients had clot lysis at 30 min (LY30) = 0, consistent with fibrinolysis shutdown, with a median of 0.1%. We did not find TEG parameters (LY30 area under the receiver operating characteristic [ROC] curve [AUC] = 0.55, 95% CI: 0.44-0.65, P value = .32; alpha angle [α] AUC = 0.58, 95% CI: 0.47-0.69, P value = .17; K time AUC = 0.58, 95% CI: 0.46-0.69, P value = .67; maximum amplitude (MA) AUC = 0.54, 95% CI: 0.44-0.64, P value = .47; reaction time [R time] AUC = 0.53, 95% CI: 0.42-0.65, P value = .70) to be a good discriminator for VTE. We also did not find TEG parameters (LY30 AUC = 0.51, 95% CI: 0.42-0.60, P value = .84; R time AUC = 0.57, 95%CI: 0.48-0.67, P value .07; α AUC = 0.59, 95%CI: 0.51-0.68, P value = .02; K time AUC = 0.62, 95% CI: 0.53-0.70, P value = .07; MA AUC = 0.65, 95% CI: 0.57-0.74, P value < .01) to be a good discriminator for thrombotic events. Conclusions In this retrospective multicenter cohort study, TEG in COVID-19 hospitalized patients may indicate a hypercoagulable state, however, its use in detecting VTE or thrombotic events is limited in this population.
Is the routine use of local antibiotics in the management of periprosthetic joint infections justified?
Gofton, Wade , Abdelbary, Hesham , Azad, Marisa , Grammatopoulos, George , Bourget-Murray, Jonathan , Azad, Marisa Ann , Garceau, Simon P.

Mayo Clinic

HIP International | November 30, 2022 | Volume: 33 | Issue: 1 | Pages: 4-16

10.1177/11207000221139467 | PMID 36447342 Get It

Periprosthetic joint infection (PJI) following total hip and total knee arthroplasty continues to be a leading cause of re-operation and revision arthroplasty. Not only is the treatment of PJI notoriously challenging, but success rates are variable. Regardless of the surgical strategy used, successful management of PJI requires a comprehensive surgical debridement focused at eradicating the underlying biofilm followed by appropriate antimicrobial therapy. Although systemic antimicrobial delivery continues to be a cornerstone in the treatment of PJI, many surgeons have started using local antibiotics to deliver higher concentrations of antibiotics directly into the vulnerable joint and adjacent soft tissues, which often have compromised vascularity. Available evidence on the use of topical powder, bone cement, and calcium sulphate carriers for local delivery of antibiotics during the initial treatment of PJI is limited to studies that are extremely heterogeneous. There is currently no level-1 evidence to support routinely using these products. Further, appropriately powered, prospective studies are needed to quantify the safety and efficacy of antibiotic-located calcium-sulphate carriers to justify their added costs. These products should not encourage surgeons to deviate from best practice guidelines, such as those recommended during the International Consensus Meeting on Musculoskeletal Infections.
Prevalence of Ocular Comorbidities in Elderly Patients with Multiple Myeloma in the US: An Analysis of 100% Medicare Sample Data during 2007-2020
Ma, Qiufei , Jalbert, Jessica J. , Zhou, Zheng‐Yi , Downes, Nathaniel , Zhang, Adina , Chi, Lei, Song, Xue, Noguera‐Troise, Irene, Weyne, Jonathan, Kroog, Glenn S. , Lorenc, Karen Rodriguez , Ailawadhi, Sikander , Zhou, Mo , Hampp, Christian

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 5272-5273

10.1182/blood-2022-158401 Get It